Cardiofaciocutaneous Syndrome 2; Cfc2
Description
Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects, and mental retardation (summary by Niihori et al., 2006). In a phenotypic comparison of BRAF (OMIM )-positive and KRAS-positive individuals with CFC, Niihori et al. (2006) observed that patients with KRAS mutations did not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma, that were present in patients with BRAF mutation.
Clinical Features
Top most frequent phenotypes and symptoms related to Cardiofaciocutaneous Syndrome 2; Cfc2
- Intellectual disability
- Global developmental delay
- Short stature
- Hypertelorism
- Ptosis
- Low-set ears
- High palate
- Peripheral neuropathy
- Myopia
- Macrocephaly
And another 25 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Cardiofaciocutaneous Syndrome 2; Cfc2 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
KRAS Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
KRAS
Specificity
100 %
Genes
100 % |
KRAS Sequence Analysis (Familial Mutation/Variant Analysis).
By Baylor Miraca Genetics Laboratories (United States).
KRAS
Specificity
100 %
Genes
100 % |
KRAS Sequence Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
KRAS
Specificity
100 %
Genes
100 % |
PreSeek Non-invasive Prenatal Gene Sequencing Screen.
By Baylor Miraca Genetics Laboratories (United States).
RIT1, BRAF, SMC1A, SOS1, SOS2, CDKL5, SYNGAP1, TSC1, TSC2, HDAC8, NSD1, CBL, SHOC2, CHD7, COL1A2, SMC3, NIPBL, FGFR2, FGFR3, HRAS , (...)
View the complete list with 9 more genes
Specificity
4 %
Genes
100 % |
KRAS/RAF1/SOS1 DNA Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SOS1, KRAS, RAF1
Specificity
34 %
Genes
100 % |
KRAS DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
KRAS
Specificity
100 %
Genes
100 % |
Non-immune Hydrops Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RIT1, RPL11, RPL35A, RPL5, RPS10, RPS17, RPS19, RPS24, RPS26, SEC23B, SLC17A5, BRAF, SMPD1, SOS1, SOS2, SOX18, UROS, CBL, SHOC2, ALG9 , (...)
View the complete list with 66 more genes
Specificity
2 %
Genes
100 % |
NGS RASopathy Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RIT1, RRAS, BRAF, SOS1, SOS2, CBL, SHOC2, KAT6B, SPRED1, A2ML1, CABIN1, NSUN2, HRAS, KRAS, LZTR1, MAP2K1, MAP2K2, NF1, NF2, NRAS , (...)
View the complete list with 3 more genes
Specificity
5 %
Genes
100 % |
You can get up to 265 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like WELANDER DISTAL MYOPATHY; WDM NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1 GELEOPHYSIC DYSPLASIA 1; GPHYSD1